investor presentation kalbe farma

Welcome to Kalbe Farma Tbk Investor Relations. We are committed to providing timely, high quality information to investors on the internet. Whether you are interested in key performance ratios, financial news and results, we hope that you will find what you need readily here.

This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. ("Kalbe"or the "Company"). This presentation has been prepared solely for use in connection with the release of 31 December 2022 audited results of the Company. The information contained in this presentation has not been independently verified.

This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. ("Kalbe" or the "Company"). This presentation has been prepared solely for use in connection with the release of 30 September 2023 unaudited results of the Company. The information contained in this presentation has not been independently verified.

Get the latest Kalbe Farma Tbk PT (KLBF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Search Investor Relations: English. IR Home; Corporate Information Board of Directors; Competitive Strengths; Prospects; Financial Information Financial Results; ... Presentations Presentation Slides; Webcast; Information Request Email Alerts; All Downloads; Online Q&A; IR FAQ; IR Contact; All Downloads.

Kalbe Farma Tbk www.nhis.co.id − PT Kalbe Farma Tbk (KLBF), founded in 1966, is a leading pharmaceutical company in Indonesia. − KLBF expands and transforms its businesses into an integrated healthcare solution embodied in its four well-diversified business divisions: Prescription Pharmaceutical (23% contribution),

Kalbe Farma 4,775 1,620 1,604 191 7.73% 11.9% 16.0% 24.8x 3.8x Kimia Farma 1,047 1,261 688 1 N/A 0.2% 0.2% 856.6x 2.2x ... Any recommendation contained herein may not be suitable for all investors. Although the information hereof is obtained from reliable sources, its accuracy and completeness cannot be guaranteed. PT NH Korindo Sekuritas ...

PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. ... First Sentier Investors (UK) IM Ltd. as of 30 Apr 2024: 691.52m: 1.48%: Norges Bank Investment Management as of 31 Dec 2023: 644.42m: 1.38% ...

This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. ("Kalbe" or the "Company"). This presentation has been prepared solely for use in connection with the release of 30 June 2023 unaudited results of the Company. The information contained in this presentation has not been independently verified.

1Q24 Unaudited Results. PT Kalbe Farma Tbk. 1 st May 2024. Forward-Looking Statement. This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. ("Kalbe" or the "Company"). This presentation has been prepared solely for use in connection with the release of 31 March 2024 unaudited results of the Company. The ...

PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions.

PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from ...

Get Kalbe Farma Tbk PT (KLBF.JK) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Search Investor Relations: English. IR Home; Corporate Information Board of Directors

This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. ("Kalbe" or the "Company"). This presentation has been prepared solely for use in connection with the release of 31 March 2023 unaudited results of the Company. The information contained in this presentation has not been independently verified.

This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. ("Kalbe" or the "Company"). This presentation has been prepared solely for use in connection with the release of 30 September 2022 unaudited results of the Company. The information contained in this presentation has not been independently verified.

Per-Share Earnings, Actuals and Estimates. View the latest Kalbe Farma (KLBF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

See the latest PT Kalbe Farma Tbk stock price (KLBF:XIDX), related news, valuation, dividends and more to help you make your investing decisions.

Get forward-looking insights from hiring trends, patenting activity, PT Kalbe Farma's innovation landscape, social media strategy and brand perception; Support your decision-making with a management outlook on innovation, investments and IP risk exposure from earnings reports, investor presentations and ESG reports; Included in this Report:

Jakarta, 30 April 2024 - PT Kalbe Farma Tbk and its subsidiaries ("Kalbe" or "the Company") today announced its unaudited financial results for the 1Q-24 period. The Company achieved a double-digit net profit growth of 11.9% YoY, driven by positive growth across all business segments, managed operational cost, and the positive impact of non ...

Search Investor Relations: English. IR Home; Corporate Information Board of Directors

股票代码： klbf: 货币： idr: 最新报价： 1420.000: 成交量 ('000)： 48,390,500: 涨跌：-25.000: 涨幅%：-1.730: 当日价格幅度： 1415.000 ...